Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis
about
Adjunctive steroid therapy for managing pulmonary tuberculosisFighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsGlucocorticoids in the management of peritumoral brain edema: a review of molecular mechanismsComplex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosisPathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis.Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis.Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome.Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary TuberculosisCommon polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis.A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam.A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.In an in vitro model of human tuberculosis, monocyte-microglial networks regulate matrix metalloproteinase-1 and -3 gene expression and secretion via a p38 mitogen activated protein kinase-dependent pathwayTuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome.Host-directed therapeutics for tuberculosis: can we harness the host?Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38 and caspase 8 dependent pathways.The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.Treatment-Associated Inflammatory Deterioration in Tuberculous Meningitis: Unpicking the Paradox.Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study.Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis.Adjunctive role of MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous meningitis.Tuberculous meningitis: treat upon suspicion.Computational modeling of tuberculous meningitis reveals an important role for tumor necrosis factor-α.Tuberculous meningitis
P2860
Q24188019-CEF4C002-2819-4D86-BAF1-C7507CE6CA05Q26774211-E353017B-1FD9-43CF-84F5-37E31E1A4AB4Q28075735-B54FAAC9-BB38-4EF6-8FCB-5E6C809E7C1AQ28817395-1A4FBB30-E8CD-4339-88D3-B260BBB775DCQ33742612-B875B922-2888-4F11-BA50-266D1D324836Q33877825-293A322B-A3D4-4120-A9D3-5D99FA1CC1CDQ34015064-86340394-0F30-4A33-926B-3200B9B32F61Q34480272-E984E9EF-8D9F-4AAE-A8E3-34E176F2E055Q34488659-3A3FDB7F-BF3C-43A2-81EC-BED45991C796Q35634195-4AA276C0-CD90-4A3D-A957-8D21FDAB090DQ35694701-A457987B-BC73-464F-ADAC-9CB2C544A534Q35913800-9D8FE52C-E445-4316-92CA-7D5CAE9213CAQ36069508-1661080F-824A-438E-8E2C-BE221D2CE674Q36612172-5F6964BB-FC9D-4F0A-9246-87E3FDDD64D9Q37152577-B57DBBE0-8C25-494A-9E8C-D545AD8C3F1DQ38041192-2593DAB9-9CB9-4A42-949D-AAC89195E02CQ38168037-648CD709-F50E-4B54-A6D3-05610CDFC2DAQ39032038-0E8890CA-A6C2-4C20-99FC-9112DB25D11AQ39344161-0F7441BB-A106-4A30-91D7-96F7541266D7Q39523548-A29A64A9-F1CE-4E75-8DAE-5AD4EE0C1937Q39569711-3F8A27CE-C46F-4B3B-96F1-3264922BD8F7Q40124133-F47C7E52-30A7-4FCE-B1B2-FB4B083906F0Q40246953-36842F43-CFD7-401E-B36E-F565096B2553Q40623056-9CE583AA-6A6C-42AD-9EC9-E6D0CA1530ADQ42052854-DA1753E8-80F8-4E14-9970-B91BEA4EBA38Q42268644-10A908A5-7BC3-4C7C-80AF-A144FD6269B6Q57827115-2AC05FD6-86F8-4791-94E1-09301C837B86
P2860
Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@ast
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@en
type
label
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@ast
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@en
prefLabel
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@ast
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@en
P2093
P2860
P50
P921
P1433
P1476
Dexamethasone, cerebrospinal f ...... omes in tuberculous meningitis
@en
P2093
Chau T H Tran
Chuong V Ly
Hien T Tran
Justin A Green
Mai T H Nguyen
Nghia D T Ho
Phu H Nguyen
Sinh X Dinh
P2860
P356
10.1371/JOURNAL.PONE.0007277
P407
P577
2009-09-30T00:00:00Z